Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Clinical trial NCT01808820 · COMPLETED

Trial details

NCT number

NCT01808820

Sponsor

Macarena De La Fuente, MD

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2013-08-21

Primary completion

2018-11-07

Enrollment

20

View on ClinicalTrials.gov